BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, May 11, 2025
Breaking News: 100 days of uncertainty
See today's BioWorld Science
Home
» Inhibiting C1q reduces ALS-derived damage in mice
To read the full story,
subscribe
or
sign in
.
Neurology/Psychiatric
Inhibiting C1q reduces ALS-derived damage in mice
Dec. 13, 2023
Amyotrophic lateral sclerosis (ALS) is associated with loss of synaptic connectivity at the neuromuscular junction (NMJ) and loss of motor neurons.
BioWorld Science
Conferences
Neurology/psychiatric